Covance is one of the world’s largest and most comprehensive drug development services companies with more than 11,000 employees in 60 countries. Covance is the market leader in toxicology services, central laboratory services, discovery services, and a top global provider of Phase III clinical trial management services.

Covance, headquartered in Princeton, New Jersey, has annual revenues greater than $2 Billion.

Through its nonclinical, clinical and commercialization services, Covance has helped pharmaceutical and biotech companies develop one-third of all prescription medicines in the market today.

Our Services:
Stacks Image 58
In the Eurocalin project, Covance will be responsible for GLP toxicology and bioanalytical examinations to characterize the Anticalins in animals. The information of these experiments will assist in identifying the desired biological effect as well as any side effects of the new drug.

For more information, please visit our website
www.covance.com